PMC:7283670 / 130129-130368 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T114","span":{"begin":217,"end":224},"obj":"Body_part"},{"id":"T115","span":{"begin":228,"end":238},"obj":"Body_part"}],"attributes":[{"id":"A114","pred":"fma_id","subj":"T114","obj":"http://purl.org/sig/ont/fma/fma9637"},{"id":"A115","pred":"fma_id","subj":"T115","obj":"http://purl.org/sig/ont/fma/fma305853"}],"text":"It has long been known that the traditional circulation‐based delivery of therapeutic agents is not as effect, prompting pharmaceutical industries to develop novel platforms for delivery of molecules to hard‐to‐reach tissues in human body."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T221","span":{"begin":3,"end":6},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T222","span":{"begin":228,"end":233},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"It has long been known that the traditional circulation‐based delivery of therapeutic agents is not as effect, prompting pharmaceutical industries to develop novel platforms for delivery of molecules to hard‐to‐reach tissues in human body."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T83486","span":{"begin":121,"end":135},"obj":"Chemical"},{"id":"T73812","span":{"begin":190,"end":199},"obj":"Chemical"}],"attributes":[{"id":"A52130","pred":"chebi_id","subj":"T83486","obj":"http://purl.obolibrary.org/obo/CHEBI_52217"},{"id":"A38972","pred":"chebi_id","subj":"T73812","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"}],"text":"It has long been known that the traditional circulation‐based delivery of therapeutic agents is not as effect, prompting pharmaceutical industries to develop novel platforms for delivery of molecules to hard‐to‐reach tissues in human body."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T1070","span":{"begin":0,"end":239},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"It has long been known that the traditional circulation‐based delivery of therapeutic agents is not as effect, prompting pharmaceutical industries to develop novel platforms for delivery of molecules to hard‐to‐reach tissues in human body."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"2694","span":{"begin":228,"end":233},"obj":"Species"}],"attributes":[{"id":"A2694","pred":"tao:has_database_id","subj":"2694","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"It has long been known that the traditional circulation‐based delivery of therapeutic agents is not as effect, prompting pharmaceutical industries to develop novel platforms for delivery of molecules to hard‐to‐reach tissues in human body."}